ProductProductWhat are Generics?
Renagel
view photo
Generic Renagel Sevelamer Hydrochloride 400/800mg

Generic Renagel is used for reducing the amount of phosphorus in the blood in patients with chronic kidney disease who are on dialysis. Generic Renagel is used for reducing the amount of phosphorus in the blood in patients with chronic kidney disease who are on dialysis.


Urinary Tract


PackagePricePer pillSavingsOrder
400mg × 10 pills$50.00$ 5.00 
400mg × 30 pills$141.00$ 4.70  $9.00
400mg × 60 pills$240.00$ 4.00  $60.00
400mg × 90 pills$339.00$ 3.77  $111.00
PackagePricePer pillSavingsOrder
800mg × 10 pills$79.80$ 7.98 
800mg × 30 pills$218.40$ 7.28  $21.00
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
Thanks very much for your kind email. I have been very very satisfied with your service and products - indeed, they have saved my relationship, after serious psot-trauamtic disorder after long periods serving in the wars in Bosnia, Afghanistan and Iraq.
It was perfect as expected and faster than i thought.
Yes, I received my order and it was much more descrete than getting it by certified mail. You have the best system.
Read more »Read more »
NewsNews
    The Case For Keryx Biopharmaceuticals' Analyst Upgrade May Be Justified - Seeking Alpha
    The Case For Keryx Biopharmaceuticals' Analyst Upgrade May Be JustifiedSeeking AlphaSince the Perifisone failure essentially made Keryx a 'one trick wonder' for the time being, the concerns expressed by numerous investors and media outlets regarding Zerenex have mostly been based on the solid entrenchment of Renagel in the market,
    A Little Confidence Goes a Long Way - DailyFinance
    A Little Confidence Goes a Long WayDailyFinanceCompared to Sanofi's (NYS: SNY) Renagel, Zerenex produced similar levels of serum phosphorus in hemodialysis patients with high levels of phosphate
    3 Biotechs Posting Big Moves - Motley Fool UK
    3 Biotechs Posting Big MovesMotley Fool UKIt was shown in the Japanese trial to work better than RenaGel
    Sanofi: Strong performance in Q1 2012 including Genzyme contribution - MarketWatch (press release)
    Sanofi: Strong performance in Q1 2012 including Genzyme contributionMarketWatch (press release)Sales of Renvela®/Renagel® were euro 147 million, an increase of 8
Live support Online Chat


Our billing is certified by
Secure shopping certificates